PMV Pharmaceuticals, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
PMVP on Nasdaq
Location
400 Alexander Park Drive, Suite 301, Princeton, NJ

Insiders trading volume in the past year

PMV Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Orbimed Advisors Llc 10%+ Owner $10.8M -$900K -7.72% Sep 10, 2025
Interwest Partners X Lp 10%+ Owner $10M Jul 13, 2021
Thilo Schroeder Director $2.46M Oct 6, 2021
David Henry Mack President and CEO, Director $632K -$62.2K -8.95% Jul 1, 2025
Euclidean Capital LLC 10%+ Owner $283K Jun 11, 2021
Robert Ticktin General Counsel & COO $105K -$24.7K -19% Jul 1, 2025
Leila Alland Chief Medical Officer $102K Sep 15, 2023
Deepika Jalota Chief Development Officer $95.8K -$35.2K -26.9% Jul 1, 2025
Michael Carulli Chief Financial Officer $64K -$30.1K -32% Jul 1, 2025
Winston Kung Coo, Cfo $23.6K May 12, 2023
Richard A. Heyman Director Jun 5, 2025
Kirsten Flowers Director Jun 5, 2025
Laurie Stelzer Director Jun 5, 2025
Carol Gallagher Director Jun 5, 2025
Charles M. Baum Director Jun 5, 2025
Peter A. Thompson Director, 10%+ Owner Jun 2, 2021
Arnold J. Levine Director Jun 5, 2025

Recent Insider Transactions by Companies or Individuals for PMV Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.